(Q45722963)

15 December 2017

hTERT rs2736098 genetic variants and susceptibility of hepatocellular carcinoma in the Chinese population: a case-control study (English)

1 reference

15 December 2017

hepatocellular carcinoma

1 reference

Chao Zhang

1

1 reference

15 December 2017

Ya-Ping Tian

2

1 reference

15 December 2017

Yue Wang

3

1 reference

15 December 2017

Feng-Hua Guo

4

1 reference

15 December 2017

Jun-Fang Qin

5

1 reference

15 December 2017

Hong Ni

6

1 reference

15 December 2017

1 February 2013

1 reference

Hepatobiliary & Pancreatic Diseases International

15 December 2017

1 reference

15 December 2017

12

1 reference

15 December 2017

74-79

1 reference

15 December 2017

1

1 reference

Hepatocellular carcinoma pathogenesis: from genes to environment

15 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Hepatocellular cancer in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Telomeres and telomerase in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Genetic variation in five genes important in telomere biology and risk for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Senescence and immortality in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Sequence variants at the TERT-CLPTM1L locus associate with many cancer types

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Polymorphisms in telomere maintenance genes and risk of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

G-308A TNF-alpha polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

MDM2 SNP309T>G polymorphism and risk of hepatocellular carcinoma: a case-control analysis in a Moroccan population.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

No association of EGF 5'UTR variant A61G and hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Prognostic relevance of hTERT mRNA expression in ductal adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

1 reference

7 January 2021

A "silent" polymorphism in the MDR1 gene changes substrate specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Genetics. SNPs, silent but not invisible.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Cyclin D1 splice variant and risk for non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: lessons from animal model studies

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Alternative lengthening of telomeres in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960009-0

7 January 2021

10.1016/S1499-3872(13)60009-0

Identifiers

DOI

1 reference

15 December 2017

1 reference